期刊文献+

丙型肝炎病毒核心抗原诊断价值的研究 被引量:1

Evaluation on Core Antigen in Diagnosis of Hepatitis C Virus
下载PDF
导出
摘要 目的探讨慢性丙型肝炎病毒核心抗原(HCV-c Ag)定量与患者病毒载量、丙型肝炎病毒抗体(HCV-Ab)、丙氨酸氨基转移酶(ALT)的相关性。方法检测88例慢性丙型肝炎患者血清HCV-c Ag、HCV-Ab、ALT及HCV RNA,并进行对比分析。结果 88例慢性丙型肝炎患者中,HCV RNA阳性率为64.8%(57/88),HCV-c Ag阳性率51.1%(45/88)。随HCV RNA浓度降低,HCV-c Ag阳性率逐渐下降(P〈0.05),HCV-c Ag浓度逐渐降低(P〈0.05)。HCV-Ab阳性率为92.0%(81/88),HCV-Ab阳性组HCV-c Ag浓度显著高于HCV-Ab阴性组(P〈0.05)。丙型肝炎患者HCV-c Ag浓度与HCV-Ab浓度呈正相关关系(P〈0.05)。ALT浓度151~250 U/L者25例(28.4%),61~150 U/L者29例(33.0%),≤60 U/L者34例(38.6%)。3组HCV-c Ag浓度比较,差异无统计学意义(P〉0.05)。结论 HCV-c Ag可作为慢性丙型肝炎患者辅助诊断的指标之一。 Objective To investigate the correlation of chronic hepatitis C virus core antigen( HCV-c Ag)quantitative detection with viral load,hepatitis C virus antibody( HCV-Ab) and ALT. Methods The serum samples of88 patients with chronic hepatitis C were collected to detect the HCV-c Ag,HCV-Ab,ALT and HCV RNA levels,and a comparative analysis was conducted. Results Among 88 patients with chronic hepatitis C,the positive rate of HCV RNA was 64. 8%( 57 /88),and the positive rate of HCV-c Ag was 51. 1%( 45 /88). The positive rate and concentration of HCV-c Ag decreased gradually with the decreasing HCV RNA concentration( P〈0. 05). The positive rate of HCV-Ab was92. 0%( 81 /88). The HCV-c Ag concentration in the positive HCV-Ab group was significant higher than that in the negative HCV-Ab group( P〈0. 05). The HCV-c Ag concentration positively correlated with the HCV-Ab concentration among hepatitis C patients( P〈0. 05). The patients with the ALT concentration of 151- 250 U / L accounted for28. 4%( 25 cases),of 61- 150 U / L 33. 0%( 29 cases),≤60 U / L 38. 6%( 34 cases). There was no significant difference in the HCV-c Ag concentration among three groups( P〈0. 05). Conclusion HCV-c Ag can be used as one of the indicators for the auxiliary diagnosis of chronic hepatitis C.
出处 《广西医学》 CAS 2014年第11期1529-1531,共3页 Guangxi Medical Journal
关键词 丙型肝炎病毒 核心抗原 定量检测 诊断 Hepatitis C virus Core antigen Quantitative detection Diagnosis
  • 相关文献

参考文献11

  • 1Webster DP, Klenerman P, Collier J, et al. Development of novel treatments for hepatitis C [ J ]. Lancet Infect Dis, 2009,9(2) :108 - 117.
  • 2陈园生,李黎,崔富强,邢文革,王璐,贾志远,周脉耕,龚晓红,王富珍,郑徽,罗会明,毕胜利,汪宁,杨维中,梁晓峰.中国丙型肝炎血清流行病学研究[J].中华流行病学杂志,2011,32(9):888-891. 被引量:308
  • 3丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 4Lavanchy D. The global burden of hepatitis C [ J ]. Liver Int,2009,29 ( Suppl 1 ) :74 - 81.
  • 5Kuo YH, Chang KC, Wang JH, et al. Is hepatitis C virus core antigen an adequate marker for community screening? [J]. J Clin Mierobiol,2012,50(6) :1 989 -1 993.
  • 6李丽,娄宏.丙肝病毒核心抗原检测的临床价值分析[J].中国误诊学杂志,2011,11(13):3086-3086. 被引量:2
  • 7Gu S, Liu J, Zhang H, et al. Core antigen tests for hepatitis C virus : a meta-analysis [ J ]. Mol Biol Rep,2012,39 ( 8 ) : 8 197 - 8 208.
  • 8Ergunay K, Sener B, Alp A, et al. Utility of a commercial quantitative hepatitis C virus core antigen assay in a diag- nostic laboratory setting [ J ]. Diagn Microbiol Infect Dis, 2011,70(4) :486 -491.
  • 9史璇.丙型肝炎病毒核心抗原的检测及其临床意义[J].军医进修学院学报,2012,33(8):845-846. 被引量:5
  • 10Durante-Mangoni E, Vallefuoco L, Sorrentino R, et al. Clini- co-pathological significance of hepatitis C virus core antigen levels in chronic infection [ J ]. J Med Virol,2013,85 ( 11 ) : 1913-1 918.

二级参考文献36

  • 1周永香.丙型肝炎病毒血症与临床关系的研究[J].临床荟萃,2004,19(24):1408-1409. 被引量:2
  • 2谢立,黄德庄,时洪波,贺丽香,靳海英.用酶联免疫夹心法测定肝炎患者血清丙型肝炎抗原[J].中华检验医学杂志,2005,28(11):1159-1162. 被引量:15
  • 3Richard P,Wenzel MD,李德淳,等.医院内感染的预防与控制[M].天津:天津科技翻译出版公司,2005:5.
  • 4戴志澄,祁国明.中国病毒性肝炎血清流行病学调查(上卷),1992-1995.北京:科学技术文献出版社,1995:60-71.
  • 5Liang XF, Bi SL, Yang WZ, et al. Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine, 2009,27 : 6550-6557.
  • 6卫生部.全国人群乙型病毒性肝炎血清流行病学调查报告.北京:人民卫生出版社,2011:1-70.
  • 7Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol, 2003,38 Suppl: S 1042-1048.
  • 8Halasz R, Weiland O, Sallberg M. GB virus C/hepatitis G virus. Scand J Infect Dis, 2001,33 (8) : 572-580.
  • 9Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C infection. Lancet Infect Dis, 2005,5 : 558-567.
  • 10Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol, 2008, 48: 148-162.

共引文献1025

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部